Elixinol Finds Non-compliant CBD Products at Japanese Subsidiary

116

Elixinol Global (ASX: EXL ,OTCQX:ELLXF) has discovered that non-compliant hemp-derived cannabidiol (CBD) products were being sold by its subsidiary Elixinol Japan. Last Wednesday (October 23), the New South Wales-based cannabis company informed investors that the breach was found during a recent review of the company’s individual business units. “The non-compliance relates to the strict requirements in Japan on sourcing CBD from only hemp stalk and seed,” the company said in a statement.

Ga naar Bron